Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Content archived on 2024-05-27

Development of a safe, efficacious bluetongue virus vaccination strategy for europe (BLUETONGUE VACCINATION)

Article Category

Article available in the following languages:

Development of tools for veterinary research

EU's livestock is often under threat from a variety of infectious diseases. Bluetongue virus (BTV) infection can lead to severe losses throughout the livestock industry.

Laying out an efficient vaccination policy, evaluating existing vaccines and developing new ones were the main aims of the BLUETONGUE VACCINATION project. Partners focused on the development of virus-like vaccines, based on inactivated virions and novel modes of delivery. As part of their efforts and ongoing studies, project partners developed a laboratory-based colony of the BTV vector, Culicoides nubeculosus (C. nuberculosu). This vector 'stockhouse' can be used by laboratories across Europe and could be of great use for the evaluation of virulence of viral strains intended for vaccine production. Furthermore, the colony was used for the testing of existing live vaccine viruses. A research tool of this nature could be valuable for all studies involving BTV and other virus-vector interactions. Continuing research and information exchange as regards BTV and its transmission can help in the formulation of an effective vaccination policy for Europe.

Discover other articles in the same domain of application